VIDEO: Post hoc analysis shows impact of better baseline vision on DME outcomes
Click Here to Manage Email Alerts
In this Healio Video Perspective, Dilraj Grewal, MD, discusses an analysis of the VISTA and VIVID studies exploring the impact of baseline vision on visual outcomes and vision-related quality of life function in diabetic macular edema.
Grewal presented results from the post hoc analysis, which examined patients with DME who were treated with 2 mg aflibercept, at the Retina Society meeting.
“Patients with better baseline vision may achieve improved visual outcomes as well as vision-related quality of life for up to 2 years of treatment,” he said.
Collapse
Grewal D. Impact of baseline vision on visual outcomes and vision-related quality of life functions in eyes with diabetic macular edema. Presented at: Retina Society meeting; Oct. 11-14, 2023; New York.
Read more about
Click Here to Manage Email Alerts